HK1215863A1 - Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof - Google Patents

Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof

Info

Publication number
HK1215863A1
HK1215863A1 HK16103825.7A HK16103825A HK1215863A1 HK 1215863 A1 HK1215863 A1 HK 1215863A1 HK 16103825 A HK16103825 A HK 16103825A HK 1215863 A1 HK1215863 A1 HK 1215863A1
Authority
HK
Hong Kong
Prior art keywords
preparation process
hyaluronic acid
acid derivatives
photocrosslinked hyaluronic
photocrosslinked
Prior art date
Application number
HK16103825.7A
Other languages
Chinese (zh)
Inventor
Monica Campisi
Lucchi Ottorino De
Riccardo Beninatto
Giuseppe Borsato
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of HK1215863A1 publication Critical patent/HK1215863A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/16—Materials with shape-memory or superelastic properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
HK16103825.7A 2013-02-06 2016-04-05 Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof HK1215863A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000162A ITMI20130162A1 (en) 2013-02-06 2013-02-06 PHOTORETIC DERIVATIVES OF HYALURONIC ACID, THEIR PROCESS OF PREPARATION AND USE
PCT/IB2014/058784 WO2014122580A1 (en) 2013-02-06 2014-02-04 Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof

Publications (1)

Publication Number Publication Date
HK1215863A1 true HK1215863A1 (en) 2016-09-23

Family

ID=47953536

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103825.7A HK1215863A1 (en) 2013-02-06 2016-04-05 Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof

Country Status (17)

Country Link
US (1) US9889226B2 (en)
EP (1) EP2953656B1 (en)
CN (1) CN104968375B (en)
CA (1) CA2900155C (en)
EA (1) EA029927B1 (en)
ES (1) ES2614742T3 (en)
HK (1) HK1215863A1 (en)
HR (1) HRP20170152T1 (en)
HU (1) HUE031774T2 (en)
IT (1) ITMI20130162A1 (en)
LT (1) LT2953656T (en)
PL (1) PL2953656T3 (en)
PT (1) PT2953656T (en)
RS (1) RS55633B1 (en)
SI (1) SI2953656T1 (en)
SM (1) SMT201700113B (en)
WO (1) WO2014122580A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220202964A1 (en) * 2019-04-24 2022-06-30 University Of Florida Research Foundation, Incorporated Heparanase compounds and methods of use
WO2021030096A1 (en) * 2019-08-09 2021-02-18 Shu-Tung And Alice Li Foundation Inc. Biopolymer-based meniscus implant
IT202000005692A1 (en) * 2020-03-17 2021-09-17 Fidia Farm Spa Bio-ink for 3D printing, its conjugate and the process of preparing an intermediate consisting of a photoreactive linker

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666897A5 (en) 1983-10-11 1988-08-31 Fidia Spa NON-INFLAMMATORY HYALURONIC ACID FRACTIONS, PHARMACEUTICAL METHODS AND COMPOSITIONS.
IT1198449B (en) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
JP2855307B2 (en) 1992-02-05 1999-02-10 生化学工業株式会社 Photoreactive glycosaminoglycans, cross-linked glycosaminoglycans and methods for producing them
WO1994024120A1 (en) * 1993-04-13 1994-10-27 Naxcor Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
EP1217008B1 (en) 2000-12-19 2006-03-01 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked hyaluronic acid derivative and medical material using the same
ITPD20020064A1 (en) * 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl FOREIGN DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGELD FOR USE IN THE BIOMEDICAL, SANITARY AND SURGICAL FIELD AND AS A SYSTEM
WO2005026214A1 (en) 2003-09-12 2005-03-24 Seikagaku Corporation Polysaccharide pseudo-sponge
AU2006266741B2 (en) * 2005-07-06 2011-09-01 Seikagaku Corporation Drug-introduced photo-crosslinked hyaluronic acid derived gel
CA2631049A1 (en) * 2007-05-10 2008-11-10 Mcmaster University Photo-responsive delivery system
CN102344501A (en) * 2011-07-08 2012-02-08 江南大学 Preparation method of coumarin-modified hyaluronic acid graft micelle emulsifier

Also Published As

Publication number Publication date
CA2900155A1 (en) 2014-08-14
LT2953656T (en) 2017-02-10
US9889226B2 (en) 2018-02-13
US20150367027A1 (en) 2015-12-24
WO2014122580A1 (en) 2014-08-14
EA029927B1 (en) 2018-05-31
CN104968375A (en) 2015-10-07
CA2900155C (en) 2021-10-19
RS55633B1 (en) 2017-06-30
HRP20170152T1 (en) 2017-03-24
SI2953656T1 (en) 2017-02-28
ES2614742T3 (en) 2017-06-01
CN104968375B (en) 2018-03-13
EP2953656A1 (en) 2015-12-16
ITMI20130162A1 (en) 2014-08-07
PL2953656T3 (en) 2017-04-28
EA201591453A1 (en) 2016-01-29
EP2953656B1 (en) 2016-11-09
PT2953656T (en) 2017-02-15
HUE031774T2 (en) 2017-07-28
SMT201700113B (en) 2017-03-08

Similar Documents

Publication Publication Date Title
EP2968304A4 (en) 4-phenylpiperidines, their preparation and use
EP2968303A4 (en) Octahydrocyclopentapyrroles, their preparation and use
IL245101B (en) 1,4-cyclohexylamine derivatives and processes for the preparation thereof
HK1212980A1 (en) Pyridinone derivatives, preparation process and pharmaceutical use thereof
HK1222664A1 (en) Heparan sulphates
HK1216146A1 (en) Ophthalmic composition, method for preparing the same, and use of the same
EP3110903A4 (en) Aqueous solution and methods for manufacture and use
ZA201601174B (en) Reverse-phase polymerisation process
IL242437B (en) 5,9-dimethyl-9-hydroxy-decen-4-al compound, its use and process for its preparation
ZA201601246B (en) Reverse-phase polymerisation process
PT3021881T (en) Cross-linked hyaluronic acid, process for the preparation thereof and use thereof in the aesthetic field
ZA201601247B (en) Reverse-phase polymerisation process
IL244755A0 (en) L process for the preparation of xanthohumol
EP3065712A4 (en) Microparticles, methods for their preparation and use
PL3055679T3 (en) Fissure-detection agent, method for the production thereof and use of the fissure-detection agent
EP2989056A4 (en) Nanoiron suspension, process for the preparation thereof its use and device for the preparation of nanoiron suspension
HK1215863A1 (en) Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof
PL2964607T3 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
EP2980096A4 (en) 2 ,3 ,5 -trihydroxy-androst-6-one and preparation methods and use thereof
PL3048934T3 (en) Flowerport comprising adjustable arms for coupling and supporting to railings, walls or other supports
PT3063231T (en) Acid dyes, process for the production thereof and their use
ZA201505621B (en) Carbodithioates with spermicidal activity and process for preparation thereof
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
GB201308136D0 (en) Agrochemical composition, method for its preparation and the use thereof
PL398021A1 (en) New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof